January 25, 2018 / 9:57 PM / 8 months ago

BRIEF-CTI Biopharma Provides Corporate And European Regulatory Update

Jan 25 (Reuters) - CTI Biopharma Corp:

* CTI BIOPHARMA PROVIDES CORPORATE AND EUROPEAN REGULATORY UPDATE

* CTI BIOPHARMA - WAS GRANTED 3 MONTH EXTENSION TO SUBMIT ITS RESPONSE TO DAY 120 LIST OF QUESTIONS FOR HUMAN USE OF EMA, REGARD TO MAA FOR PACRITINIB

* CTI BIOPHARMA CORP - CO ANTICIPATES SUBMITTING ITS RESPONSE TO D120 LOQ IN MAY 2018

* CTI BIOPHARMA CORP - CO REINCORPORATED IN STATE OF DELAWARE, DELISTED FROM BORSA ITALIANA MTA EXCHANGE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below